Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology

被引:0
|
作者
Davide Gnocchi
Carlo Custodero
Carlo Sabbà
Antonio Mazzocca
机构
[1] University of Bari School of Medicine,Interdisciplinary Department of Medicine
来源
关键词
Non-alcoholic fatty liver disease (NAFLD); Non-alcoholic steatohepatitis (NASH); Hepatocellular carcinoma (HCC); Circadian rhythms; Metabolism; Metabolic syndrome; Insulin resistance;
D O I
暂无
中图分类号
学科分类号
摘要
Over the last decades, a better knowledge of the molecular machinery supervising the regulation of circadian clocks has been achieved, and numerous findings have helped in unravelling the outstanding significance of the molecular clock for the proper regulation of our physiologic and metabolic homeostasis. Non-alcoholic fatty liver disease (NAFLD) is currently considered as one of the emerging liver pathologies in the Western countries due to the modification of eating habits and lifestyle. Although NAFLD is considered a pretty benign condition, it can progress towards non-alcoholic steatohepatitis (NASH) and eventually hepatocellular carcinoma (HCC). The pathogenic mechanisms involved in NAFLD development are complex, since this disease is a multifactorial condition. Major metabolic deregulations along with a genetic background are believed to take part in this process. In this light, the aim of this review is to give a comprehensive description of how our circadian machinery is regulated and to describe to what extent our internal clock is involved in the regulation of hormonal and metabolic homeostasis, and by extension in the development and progression of NAFLD/NASH and eventually in the onset of HCC.
引用
收藏
页码:741 / 759
页数:18
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [32] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [33] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [34] Non-alcoholic fatty liver disease: Epidemiology, pathophysiology and an update on the therapeutic approaches
    Abdel-Rahman, Rehab F.
    ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, 2022, 12 (03) : 99 - 114
  • [35] The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics
    Malladi, Navya
    Alam, Md Jahangir
    Maulik, Subir K.
    Banerjee, Sanjay K.
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2023, 169
  • [36] The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
    Perakakis, Nikolaos
    Stefanakis, Konstantinos
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 111
  • [37] Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
    Memaj, Plator
    Jornayvaz, Francois R.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [38] Non-alcoholic fatty liver disease: Epidemiology, pathophysiology and an update on the therapeutic approaches
    Rehab F.Abdel-Rahman
    Asian Pacific Journal of Tropical Biomedicine, 2022, (03) : 99 - 114
  • [39] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [40] Pathophysiology of Non Alcoholic Fatty Liver Disease
    Petta, Salvatore
    Gastaldelli, Amalia
    Rebelos, Eleni
    Bugianesi, Elisabetta
    Messa, Piergiorgio
    Miele, Luca
    Svegliati-Baroni, Gianluca
    Valenti, Luca
    Bonino, Ferruccio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12)